Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
Around the world, Coronary Artery Disease (CAD) is quickly becoming the most common cause of morbidity and mortality. Percutaneous coronary interventions- angioplasty and stent insertion- have proved effective and reliable treatments for CAD but their long-term efficacy is limited by the high rate o...
Saved in:
Main Authors: | P Ranjzad (Author), PA Kingston (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2005-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gene Therapy for the Prevention of in- Stent Restenosis Post Coronary Angioplasty
by: P Ranjzad, et al.
Published: (2005) -
Factors Associated with In-stent Restenosis in Patients Following Percutaneous Coronary Intervention
by: Dedi Wihanda, et al.
Published: (2015) -
Targeting the epigenome in in-stent restenosis: from mechanisms to therapy
by: Xi Yang, et al.
Published: (2021) -
Nanocarrier Design for Dual-Targeted Therapy of In-Stent Restenosis
by: Ivan S. Alferiev, et al.
Published: (2024) -
Analysis of influencing factors for restenosis after percutaneous transluminal angioplasty in hemodialysis patients
by: Shen Zhan, et al.
Published: (2024)